Correlates and Heritability of Nonalcoholic Fatty Liver Disease in a Minority Cohort

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Obesity

• Publication date

  2009-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/oby.2009.4PMID 19584882PMCID PMC2709735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Comparison of CT methods for determining the fat content of the liver.

  2007cited by this paper
• Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population: National Health and Nutrition Examination Survey 1999–2002

  2007cited by this paper
• Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans.

  2007cited by this paper
• Prevalence of overweight and obesity in the United States, 1999-2004.

  2006cited by this paper
• The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.

  2006cited by this paper
• Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population

  2006cited by this paper
• Heritability and genetic loci of fatty liver in familial combined hyperlipidemia Published, JLR Papers in Press, September 13, 2006.

  2006cited by this paper
• The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults

  2006cited by this paper
• Long‐term follow‐up of patients with NAFLD and elevated liver enzymes

  2006cited by this paper
• Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease.

  2006cited by this paper
• Protocol for measurement of liver fat by computed tomography.

  2006cited by this paper
• The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease

  2006cited by this paper
• The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

  2005cited by this paper
• Non‐alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non‐diabetic men. Role of visceral adipose tissue

  2005cited by this paper
• Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease

  2005cited by this paper
• Relationship between serum adiponectin concentration, pulse wave velocity and nonalcoholic fatty liver disease.

  2005cited by this paper
• Increasing prevalence of the metabolic syndrome among u.s. Adults.

  2004cited by this paper
• Hypoadiponectinemia is closely associated with nonalcoholic hepatic steatosis in obese subjects.

  2004cited by this paper
• Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

  2004influential reference
• Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance.

  2003cited by this paper
• The prevalence and etiology of elevated aminotransferase levels in the United States

  2003cited by this paper
• Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods.

  2003cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study.

  2001cited by this paper
• Multipoint quantitative-trait linkage analysis in general pedigrees.

  1998cited by this paper
• Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.

  1997cited by this paper
• Increased Insulin Resistance and Insulin Secretion in Nondiabetic African-Americans and Hispanics Compared With Non-Hispanic Whites: The Insulin Resistance Atherosclerosis Study

  1996cited by this paper
• Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin.

  1995cited by this paper
• The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results.

  1995cited by this paper
• Reduced Sample Number for Calculation of Insulin Sensitivity and Glucose Effectiveness From the Minimal Model: Suitability for Use in Population Studies

  1993cited by this paper
• Sample preparation for plasma measurement of plasminogen activator inhibitor-1 antigen in large population studies.

  1993cited by this paper
• Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects.

  1990cited by this paper
• Measurement of plasminogen activator inhibitor 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assays.

  1990cited by this paper
• MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test.

  1986cited by this paper
• Assessment of insulin sensitivity in vivo.

  1985cited by this paper
• Coated charcoal immunoassay of insulin.

  1965cited by this paper
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

  1957cited by this paper
• [Rapid physiological coagulation method in determination of fibrinogen].

  1957cited by this paper

• Gene-based therapies for steatotic liver disease.

  2025cites this paper
• Functional compartmentalization of hepatic mitochondrial subpopulations during MASH progression

  2025cites this paper
• Unraveling Mechanisms of Genetic Risks in Metabolic Dysfunction-Associated Steatotic Liver Diseases: A Pathway to Precision Medicine.

  2025cites this paper
• The Long-Term Effect of Weight Loss on the Prevention of Progression to Cirrhosis among Patients with Obesity and MASH-Related F3 Liver Fibrosis

  2024cites this paper
• Mechanisms of hepatic steatosis in chickens: integrated analysis of the host genome, molecular phenomics and gut microbiome

  2024cites this paper
• Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging Therapies

  2023cites this paper
• Application of machine learning in predicting non-alcoholic fatty liver disease using anthropometric and body composition indices

  2023cites this paper
• Non-alcoholic fatty liver disease: a clinical review

  2022cites this paper
• The association of non‐alcoholic fatty liver disease between parents and adolescent children

  2022cites this paper
• Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease

  2022cites this paper
• Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring

  2022cites this paper
• Plasminogen Activator Inhibitor-1 Levels in Non-alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis.

  2022influential citation
• Statins in Alcoholic and Non-Alcoholic Fatty Liver Disease and Chronically Elevated Liver Enzymes

  2022cites this paper
• Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD).

  2021influential citation
• Association of Visceral Adipose Tissue and Insulin Resistance with Incident Metabolic Syndrome Independent of Obesity Status: The IRAS Family Study

  2021cites this paper
• Genetics of Obesity: What We Have Learned Over Decades of Research

  2021cites this paper
• Nonalcoholic Fatty Liver Disease

  2021cites this paper
• Metabolic dysfunction‐associated fatty liver disease and liver fibrosis: Prevalence and associated factors in the middle‐aged and older US population

  2021influential citation
• Genetics Is of the Essence to Face NAFLD

  2021influential citation
• Racial differences in prevalence and severity of non-alcoholic fatty liver disease

  2021cites this paper
• Childhood obesity and the associated rise in cardiometabolic complications

  2020cites this paper
• Association of HSD17B13 rs72613567:TA with non‐alcoholic fatty liver disease in Hispanics/Latinos

  2020cites this paper
• Ethnic perception of obesity in fatty liver disease

  2020influential citation
• African Americans have a distinct clinical and histologic profile with lower prevalence of NASH and advanced fibrosis relative to Caucasians.

  2020cites this paper
• Racial Disparities in Diagnosis and Prognosis of Nonalcoholic Fatty Liver Disease

  2020cites this paper
• Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis.

  2020cites this paper
• Propensity for Intra-abdominal and Hepatic Adiposity Varies Among Ethnic Groups.

  2019cites this paper
• Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology

  2019cites this paper
• Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis

  2019cites this paper
• ROLES OF FAMILY DOCTORS IN SCREENING FOR FATTY LIVER DISEASE

  2019cites this paper
• Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics

  2019cites this paper
• Genetics of nonalcoholic fatty liver disease in Asian populations

  2019cites this paper
• A small supernumerary marker chromosome resulting in mosaic partial tetrasomy 4q26-q31.21 in a foetus with multiple congenital malformations

  2019cites this paper
• Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications

  2019cites this paper
• Evaluating the accuracy and sensitivity of anthropometric and laboratory variables in diagnosing the liver steatosis and fibrosis in adolescents with non-alcoholic fatty liver disease

  2018cites this paper
• The Extending Spectrum of NPC1-Related Human Disorders: From Niemann–Pick C1 Disease to Obesity

  2018cites this paper
• Identification of molecular pathophysiological mechanismsof non-alcoholic fatty liver disease (NAFLD)

  2018cites this paper
• Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

  2018cites this paper
• Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics.

  2018cites this paper
• Chronic liver diseases and the potential use of S-adenosyl-L-methionine as a hepatoprotector.

  2018cites this paper
• The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

  2018cites this paper
• NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances

  2018cites this paper
• The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD)

  2018cites this paper
• Molecular pathways of nonalcoholic fatty liver disease development and progression

  2018cites this paper
• Variation in particular biochemical indicators, cytokine and adipokine profiles of the blood, and the structural and functional parameters of the liver in patients with nonalcoholic fatty liver disease and different genotypes by the polymorphic locus A313G of the GSTP1 gene

  2017cites this paper
• Genetic predisposition in nonalcoholic fatty liver disease

  2017cites this paper
• Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop

  2017cites this paper
• [Non alcoholic steatohepatitis (NASH)].

  2016cites this paper
• The Prevalence and Pathobiology of Nonalcoholic Fatty Liver Disease in Patients of Different Races or Ethnicities.

  2016cites this paper
• Are Hypothyroidism and Obstructive Sleep Apnea Independent Risk Factors for the Development of Non-Alcoholic Fatty Liver Disease?

  2016cites this paper
• Are Hypothyroidism and Obstructive Sleep Apnea Independent Risk Factors for the Development of Non-alcoholic Fatty Liver Disease?: 901

  2016cites this paper
• Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort

  2016cites this paper
• Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations

  2016cites this paper
• Epidemiology and natural history of non-alcoholic fatty liver disease.

  2016cites this paper
• Incidence and Factors Associated With Nonalcoholic Fatty Liver Disease Among Patients With Rheumatoid Arthritis

  2016cites this paper
• Sex and Ethnic Differences in the Association of Obesity With Risk of Hepatocellular Carcinoma.

  2016cites this paper
• Identification of eQTLs for Hepatic Xbp1s and Socs3 Gene Expression in Mice Fed a High-Fat, High-Caloric Diet

  2015cites this paper
• Prevalence of Nonalcoholic Fatty Liver Disease and Economy

  2015cites this paper
• Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease

  2015cites this paper
• Genetic analysis of nonalcoholic fatty liver disease within a Caribbean–Hispanic population

  2015cites this paper
• Management and diagnosis of fatty liver disease

  2015cites this paper
• Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.

  2015cites this paper
• Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

  2015cites this paper
• Clinical, biochemical and histological differences between HIV‐associated NAFLD and primary NAFLD: a case–control study

  2015cites this paper
• Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease

  2015cites this paper
• Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis

  2014cites this paper
• Liver Disease in the Adolescent

  2014influential citation
• Gender and racial differences in nonalcoholic fatty liver disease.

  2014cites this paper
• Steatosis and Steatohepatitis: Complex Disorders

  2014cites this paper
• Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.

  2014cites this paper
• The prevalence of nonalcoholic fatty liver disease in the Americas.

  2014cites this paper
• Nonalcoholic Fatty Liver Disease

  2014cites this paper
• Sikliği Artan Bir Halk Sağliği Sorunu: Non-Alkolik Yağli Karaciğer Hastaliği (A Public Health Issue that Increased Prevelance: Non-Acholic Fatty Liver Disease)

  2014cites this paper
• Investigating metabolically healthy obesity in US minority populations: The IRAS Family study

  2014cites this paper
• DISSECTING THE ROLES OF TRIM24 IN REGULATION OF HEPATIC LIPID METABOLISM AND INFLAMMATION

  2014cites this paper
• Examining the contribution of genetic variants to cardiometabolic traits

  2014cites this paper
• Progression et tests diagnostiques de la stéatose hépatique non alcoolique

  2014cites this paper
• Sıklığı Artan Bir Halk Sağlığı Sorunu: Non-Alkolik Yağlı Karaciğer Hastalığı [A Public Health Issue that Increased Prevelance: Non-Acholic Fatty Liver Disease]

  2014cites this paper
• Hepatic fatty acid trafficking: multiple forks in the road.

  2013cites this paper
• Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment

  2013cites this paper
• The Prevalence and Clinical Correlates of Nonalcoholic Fatty Liver Disease (NAFLD) in African Americans: The Multiethnic Study of Atherosclerosis (MESA)

  2013cites this paper
• Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease - A historical prospective

  2013cites this paper
• A Metabolically Healthy Obese Phenotype in Hispanic Participants in the IRAS Family Study

  2013influential citation
• Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

  2013influential citation
• Non‐Alcoholic Fatty Liver Disease in South America and Hispanic people

  2013cites this paper
• Estimating the Contributions of Rare and Common Genetic Variations and Clinical Measures to a Model Trait: Adiponectin

  2013cites this paper
• Racial/ethnic differences in hepatic steatosis in a population‐based cohort of post‐menopausal women: the Michigan Study of Women's Health Across the Nation

  2013cites this paper
• Race and the insulin resistance syndrome.

  2013cites this paper
• Characterization of european ancestry nonalcoholic fatty liver disease‐associated variants in individuals of african and hispanic descent

  2013cites this paper
• Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets

  2013influential citation
• Molecular Interactions between NAFLD and Xenobiotic Metabolism

  2013cites this paper
• Heritability of non‐alcoholic fatty liver disease and association with abnormal vascular parameters: A twin study

  2012cites this paper
• Lifestyle Factors and 5‐Year Abdominal Fat Accumulation in a Minority Cohort: The IRAS Family Study

  2012cites this paper
• Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI family heart study

  2012cites this paper
• Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

  2012cites this paper
• Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.

  2012cites this paper
• Cholesteryl ester transfer protein gene polymorphisms increase the risk of fatty liver in females independent of adiposity

  2012cites this paper
• Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis

  2012influential citation
• The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

  2012cites this paper
• The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

  2012cites this paper